U.S. Levodopa prices, which had a very minor increase in August 2025, are expected to modestly increase again in September, according to experts in the market. Levodopa is one of the most critical medicines used mostly in the treatment of Parkinson's disease, and it usually has steady demand regardless of the time of year. But recent supply chain mishaps, increasing freight rates, and upcoming Chinese export closures during the Golden Week holiday will continue to support a soft upward trend. The inflationary impetus in the U.S. is also adding to the cost base, leading purchasers to purchase guardedly anticipating eventual delays.
